Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Rimšeliene, Gražina ^a,b   Nilsen, Øivind ^b   Kløvstad, Hilde ^b   Blystad, Hans ^b   Aavitsland, Preben ^b  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEPATITIS; ADULT; AGE; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MASS SCREENING; NORWAY; SEX RATIO; SEXUAL BEHAVIOR; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 79957472552     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-153     Document Type: Article

References (28)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. [Review] [20 refs]. Journal of Clinical Virology 2005, 34(Suppl-3).
2. Wands JR. Prevention of hepatocellular carcinoma. New England Journal of Medicine 2004, 351:1567-1570. 10.1056/NEJMe048237, 15470221.
3. WHO Hepatitis B. Factsheet No204. 2008, WHO.
4. ECDC Surveillance and prevention of hepatitis B and C in Europe. ECDC technical report 2010, ECDC, ECDC.
5. ECDC Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening practices 2010, ECDC.
6. Dalgard O, Skaug K. Prevalence of HBV serum markers in the general adult population of Oslo. 2005,
7. De Vos JY, Elseviers M, Harrington M, Zampieron A, Vlaminck H, Ormandy P, Kafkia T. EDTNA/ERCA Research Board Infection control practice across Europe: results of the EPD. Edtna-Erca Journal 2006, 32:38-41.
8. Kristiansen MG, Eriksen BO, Maltau JM, Holdo B, Gutteberg TJ, Mortensen L, Lochen ML, Florholmen J. Prevalences of viremic hepatitis C and viremic hepatitis B in pregnant women in Northern Norway. Hepato-Gastroenterology 2009, 56:1141-1145.
9. Iwarson S. Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK). Vaccine 1998, 16(Suppl-4).
10. Blystad H, Nils T. Outbreak of Hepatitis A and Hepatitis B among Injecting drug users in Norway, 1995-1999. EpiNorth 2000, 4:57-59.
11. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. [Review] [63 refs]. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin 13:2008.
12. Marschall T, Kretzschmar M, Mangen MJ, Schalm S. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. European Journal of Gastroenterology & Hepatology 2008, 20:1214-1225. 10.1097/MEG.0b013e32830e289e, 19308310.
13. Shiffman ML. Management of acute hepatitis B. [Review] [86 refs]. Clinics in Liver Disease/20 14:75-91.
14. Blystad H, Blad L, Tulisov A, Aavitsland P. Hepatitis B in northwest Russia and the Nordic and Baltic countries: recent trends and prevention activities. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin 2005, 10:E050310.
15. Paat G, la A, Tefanova V, Tallo T, gi L, Ahi K. The trends and risk factors for hepatitis B occurrence in Estonia. Central European Journal of Public Health 2009, 17:108-111.
16. United Nations Office on Drugs and Crime - UNODC World Drug Report 2008 2008, United Nations Office on Drugs and Crime - UNODC.
17. Skretting A, Edkand-Gryt M, Bryhni A, Rise J. The Drug Situation in Norway 2009. Annual report to the European Monitoring Centre for Drugs and Drug Addiction - EMCDDA 2010,
18. Wiessing L, Klempova D, Hedrich D, Montanari L, Gyarmathy VA. Injecting drug use in Europe: stable or declining. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin 15:2010.
19. Skaug K, Nilsen T, Holberg-Petersen M, Nilsen FL. [MSIS-report: HIV-infection among intrevenous drug users] (Norwegian) 2008, Norwegian institute of Public Health.
20. Fisker N, Pedersen C, Lange M, Nguyen NT, Nguyen KT, Georgsen J, Christensen PB. Molecular epidemiology of hepatitis B virus infections in Denmark. Journal of Clinical Virology 2004, 31:46-52. 10.1016/j.jcv.2004.05.004, 15288613.
21. van Houdt R, Koedijk FD, Bruisten SM, Coul EL, Heijnen ML, Waldhober Q, Veldhuijzen IK, Richardus JH, Schutten M, van Doornum GJ, de Man RA, Coutinho RA, Boot HJ. Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work?. Vaccine 2009, 27:3530-3535. 10.1016/j.vaccine.2009.03.072, 19464531.
22. van Houdt R, Bruisten SM, Geskus RB, Bakker M, Wolthers KC, Prins M, Coutinho RA. Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. Journal of Viral Hepatitis 2010, 17:108-114. 10.1111/j.1365-2893.2009.01158.x, 19811610.
23. Jakopanec I, Schimmer B, Grjibovski AM, Klouman E, Aavitsland P. Self-reported sexually transmitted infections and their correlates among men who have sex with men in Norway: an Internet-based cross-sectional survey. BMC Infectious Diseases 2010, 10:261. 10.1186/1471-2334-10-261, 2944348, 20815931.
24. Gilbert LK, Levandowski BA, Scanlon KE, Peterson RS. A comparison of hepatitis A and hepatitis B measures among vaccinated and susceptible online men who have sex with men. International Journal of STD & AIDS 2010, 21:400-405. 10.1258/ijsa.2009.009010, 3084795, 21559435.
25. Træen B, Stigum H, Magnus P. [Report of sex surveys in 1987, 1992, 1997 and 2002] (Norwegian) 2003, Norwegian Institute of Public Health.
26. Lavanchy D. Chronic viral hepatitis as a public health issue in the world. [Review] [99 refs]. Best Practice & Research in Clinical Gastroenterology 2008, 22:991-1008. 10.1016/j.bpg.2008.11.002, 21617968.
27. Baars JE, Boon BJ, Garretsen HF, van de Mheen D. The reach of a free hepatitis B vaccination programme: results of a Dutch study among drug users. International Journal of Drug Policy 2010, 21:247-250. 10.1016/j.drugpo.2009.07.001, 19700297.
28. Kretzschmar M, Mangen MJ, van de Laar M, de WA. Model based analysis of hepatitis B vaccination strategies in the Netherlands. Vaccine 2009, 27:1254-1260. 10.1016/j.vaccine.2008.12.009, 19118594.